Development Milestone Events. In further consideration of the licenses and rights granted to Novartis hereunder, upon [***] achievement by Novartis, its Affiliates, or its or their Sublicensees of a Development Milestone Event set forth below [***], the corresponding [***] Development Milestone Payment shall become payable by Novartis to Legend: 1) [***] [***] 1) [***] [***] 1) [***] [***] 1) [***] [***] 1) [***] [***] 1) [***] [***] 1) [***] [***]
Appears in 2 contracts
Sources: License Agreement (Legend Biotech Corp), License Agreement (Legend Biotech Corp)